INTERNATIONAL PATENT: NOVARTIS AG, ARTIOS PHARMA LIMITED FILES APPLICATION FOR "COMBINATION THERAPIES WITH DNA DAMAGE RESPONSE INHIBITORS AND [ 177LU]LU-PSMA-617"

GENEVA, Oct. 15 -- NOVARTIS AG (Lichtstrasse 354056 Basel), ARTIOS PHARMA LIMITED (Babraham HallBabraham Research CampusCambridge, Cambridgeshire CB22 3AT) filed a patent application (PCT/IB2025/053608) for "COMBINATION THERAPIES WITH DNA DAMAGE RESPONSE INHIBITORS AND [ 177LU]LU-PSMA-617" on Apr 04, 2025. With publication no. WO/2025/210599, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HINDUPUR, Sravanth Kumar (c/o Novartis Pharma AGLichtstrasse 344056 Basel), PINTO DO COUTO E SILVA, Joana (c/o Novartis Pharma AGLicht...